PROCEPT BioRobotics

Update in progress

PRCT (NasdaqGM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

PROCEPT BioRobotics Corporation is a surgical robotics company that develops solutions for urology globally. It designs, manufactures, and sells the AquaBeam Robotic System, an image-guided, minimally invasive platform for urologic surgery, focusing on benign prostatic hyperplasia. It also offers the HYDROS Robotic System for Aquablation therapy. Founded in 2007, it is headquartered in San Jose, California.

Company score

Sentiment: 0.25; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.31; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.02; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.10; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.17; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive